{
  "compound_id": "DB00244",
  "compound_name": "Mesalazine",
  "compound_percentile": 0.904411764705882,
  "disease_id": "DOID:2531",
  "disease_name": "hematologic cancer",
  "disease_percentile": 0.6710013003901171,
  "metapath_contribution": {
    "CbGaD": 0.3146635067273685,
    "CbGbCtD": 0.23738555018828736,
    "CbGdCrCtD": 0.002248934492820777,
    "CbGeAlD": 0.03251393647062266,
    "CbGpPWpGaD": 0.11439145971162878,
    "CcSEcCtD": 0.17132027730064903,
    "CrCbGaD": 0.0026259861520275076,
    "CrCrCtD": 0.1248503489565954
  },
  "n_trials": 0.0,
  "prediction": 0.0031709160110699602,
  "status": 0,
  "training_prediction": 0.0460467984565535
}